![]() |
Volumn 39, Issue 3, 2001, Pages 930-935
|
Clinical significance and taxonomy of Actinobacillus hominis
a
a
a
a
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPICILLIN;
CIPROFLOXACIN;
ERYTHROMYCIN;
GENTAMICIN;
MANNOSE;
PENICILLIN G;
POLYMYXIN;
TETRACYCLINE;
ACTINOBACILLUS;
ACTINOBACILLUS HOMINIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIMICROBIAL THERAPY;
ARTICLE;
BACTEREMIA;
BACTERIUM IDENTIFICATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DNA DNA HYBRIDIZATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LOWER RESPIRATORY TRACT INFECTION;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
SPECIES DIFFERENCE;
STRAIN DIFFERENCE;
TAXONOMY;
ACTINOBACILLUS;
ACTINOBACILLUS INFECTIONS;
ADULT;
AGED;
AGED, 80 AND OVER;
BACTEREMIA;
BACTERIAL TYPING TECHNIQUES;
FEMALE;
HUMANS;
IMMUNOCOMPROMISED HOST;
MALE;
MIDDLE AGED;
NUCLEIC ACID HYBRIDIZATION;
RESPIRATORY TRACT INFECTIONS;
RIBOTYPING;
ACTINOBACILLUS EQUULI;
ACTINOBACILLUS HOMINIS;
ANIMALIA;
BACTERIA (MICROORGANISMS);
NEGIBACTERIA;
|
EID: 0035094861
PISSN: 00951137
EISSN: None
Source Type: Journal
DOI: 10.1128/JCM.39.3.930-935.2001 Document Type: Article |
Times cited : (18)
|
References (12)
|